Nifty
Sensex
:
:
18210.95
61143.33
-57.45 (-0.31%)
-206.93 (-0.34%)

Pharmaceuticals & Drugs - Global

Rating :
31/99

BSE: 506690 | NSE: UNICHEMLAB

242.80
26-Oct-2021
  • Open
  • High
  • Low
  • Previous Close
  •  237.05
  •  246.50
  •  231.90
  •  235.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  52135
  •  124.19
  •  375.00
  •  218.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,701.35
  • 84.50
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,719.53
  • 1.66%
  • 0.68

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.93%
  • 2.46%
  • 30.50%
  • FII
  • DII
  • Others
  • 1.53%
  • 8.45%
  • 6.13%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.50
  • -4.32
  • 1.30

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.39
  • -12.97
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.95
  • -20.40
  • 83.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.16
  • 0.64
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.87
  • 1.49
  • 0.61

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.38
  • 25.02
  • 35.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
297.91
317.23
-6.09%
274.12
290.20
-5.54%
326.28
274.83
18.72%
317.51
268.14
18.41%
Expenses
299.55
305.15
-1.84%
255.07
276.83
-7.86%
296.17
291.99
1.43%
287.65
294.94
-2.47%
EBITDA
-1.64
12.08
-
19.05
13.36
42.59%
30.12
-17.16
-
29.86
-26.81
-
EBIDTM
-0.55%
3.81%
6.95%
4.60%
9.23%
-6.24%
9.40%
-10.00%
Other Income
15.79
16.71
-5.51%
7.83
11.82
-33.76%
15.61
25.10
-37.81%
10.04
28.13
-64.31%
Interest
0.99
1.25
-20.80%
1.81
2.40
-24.58%
1.27
2.32
-45.26%
0.79
1.86
-57.53%
Depreciation
22.12
20.54
7.69%
21.87
22.96
-4.75%
20.82
19.47
6.93%
21.13
20.98
0.71%
PBT
-8.96
7.00
-
3.19
-0.17
-
23.64
-13.85
-
17.98
-21.51
-
Tax
2.45
4.61
-46.85%
3.37
17.63
-80.88%
-0.07
1.20
-
9.25
0.68
1,260.29%
PAT
-11.41
2.39
-
-0.17
-17.80
-
23.71
-15.05
-
8.74
-22.19
-
PATM
-3.83%
0.75%
-0.06%
-6.13%
7.27%
-5.48%
2.75%
-8.27%
EPS
-1.63
0.35
-
-0.06
-2.44
-
3.35
-2.07
-
1.24
-3.15
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
1,215.82
1,235.14
1,103.71
1,188.19
1,379.90
1,540.06
1,332.65
1,201.79
1,133.45
1,080.80
875.46
Net Sales Growth
5.69%
11.91%
-7.11%
-13.89%
-10.40%
15.56%
10.89%
6.03%
4.87%
23.46%
 
Cost Of Goods Sold
371.99
302.14
308.63
364.19
274.97
188.77
386.97
378.57
332.84
343.06
278.55
Gross Profit
843.83
933.00
795.08
823.99
1,104.93
1,351.28
945.67
823.23
800.61
737.75
596.91
GP Margin
69.40%
75.54%
72.04%
69.35%
80.07%
87.74%
70.96%
68.50%
70.63%
68.26%
68.18%
Total Expenditure
1,138.44
1,144.03
1,154.53
1,269.21
1,358.21
1,357.62
1,168.77
1,100.79
955.75
910.06
759.42
Power & Fuel Cost
-
68.89
73.02
76.39
49.23
41.62
38.25
39.39
35.97
31.36
26.22
% Of Sales
-
5.58%
6.62%
6.43%
3.57%
2.70%
2.87%
3.28%
3.17%
2.90%
2.99%
Employee Cost
-
306.97
273.28
238.52
200.64
169.04
255.92
223.20
187.37
164.88
140.06
% Of Sales
-
24.85%
24.76%
20.07%
14.54%
10.98%
19.20%
18.57%
16.53%
15.26%
16.00%
Manufacturing Exp.
-
215.73
232.08
147.23
125.30
103.70
150.54
145.03
137.05
119.15
101.54
% Of Sales
-
17.47%
21.03%
12.39%
9.08%
6.73%
11.30%
12.07%
12.09%
11.02%
11.60%
General & Admin Exp.
-
123.98
147.90
229.37
594.53
744.66
167.66
153.29
127.77
104.73
88.54
% Of Sales
-
10.04%
13.40%
19.30%
43.09%
48.35%
12.58%
12.76%
11.27%
9.69%
10.11%
Selling & Distn. Exp.
-
122.52
116.12
197.24
108.38
107.77
166.84
157.12
134.03
135.93
116.00
% Of Sales
-
9.92%
10.52%
16.60%
7.85%
7.00%
12.52%
13.07%
11.82%
12.58%
13.25%
Miscellaneous Exp.
-
3.81
3.50
16.26
5.16
2.06
2.58
4.19
0.73
10.97
116.00
% Of Sales
-
0.31%
0.32%
1.37%
0.37%
0.13%
0.19%
0.35%
0.06%
1.01%
0.97%
EBITDA
77.39
91.11
-50.82
-81.02
21.69
182.44
163.88
101.00
177.70
170.74
116.04
EBITDA Margin
6.37%
7.38%
-4.60%
-6.82%
1.57%
11.85%
12.30%
8.40%
15.68%
15.80%
13.25%
Other Income
49.27
50.19
91.31
98.41
3,278.19
5.50
19.11
20.72
42.38
16.96
12.50
Interest
4.86
5.12
7.85
7.52
8.01
3.36
2.90
3.04
3.19
3.29
4.08
Depreciation
85.94
84.36
81.67
67.37
50.51
43.52
38.79
41.27
45.72
38.34
30.43
PBT
35.85
51.82
-49.02
-57.50
3,241.36
141.07
141.31
77.41
171.17
146.07
94.03
Tax
15.00
17.15
11.97
-33.64
696.23
32.58
29.30
2.13
43.00
32.85
22.77
Tax Rate
41.84%
33.10%
-24.42%
58.50%
21.48%
23.09%
21.27%
2.75%
25.12%
22.49%
24.22%
PAT
20.87
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
PAT before Minority Interest
20.87
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
1.72%
2.81%
-5.53%
-2.01%
184.44%
7.04%
8.14%
6.26%
11.31%
10.48%
8.14%
PAT Growth
139.64%
-
-
-
2,245.96%
0.01%
44.10%
-41.26%
13.19%
58.90%
 
EPS
2.96
4.92
-8.66
-3.39
361.52
15.41
15.41
10.69
18.20
16.08
10.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
954.33
867.52
816.61
727.07
660.58
Share Capital
14.08
14.08
14.08
14.07
18.18
18.17
18.15
18.13
18.09
18.06
Total Reserves
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
935.01
848.52
797.74
707.98
641.80
Non-Current Liabilities
49.16
43.72
10.10
46.46
64.49
76.02
74.21
97.72
94.31
92.67
Secured Loans
0.00
0.00
0.00
0.33
0.44
22.98
20.35
24.65
20.89
20.47
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
23.49
Long Term Provisions
30.41
23.51
14.60
10.76
25.33
12.58
8.88
7.64
9.19
10.24
Current Liabilities
505.76
566.73
502.92
463.51
392.62
275.09
211.76
230.32
251.12
233.30
Trade Payables
210.08
250.22
221.41
226.23
210.73
163.95
138.23
150.52
156.63
140.30
Other Current Liabilities
176.97
122.04
68.45
63.03
68.01
60.56
45.86
32.99
36.65
34.28
Short Term Borrowings
100.63
184.03
199.67
150.29
97.62
12.93
1.63
1.04
6.17
25.42
Short Term Provisions
18.09
10.44
13.39
23.97
16.25
37.65
26.05
45.78
51.67
33.30
Total Liabilities
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
1,153.49
1,144.65
1,072.50
986.55
Net Block
880.42
866.06
806.29
574.45
487.22
402.60
415.99
419.29
447.76
408.39
Gross Block
1,193.56
1,098.27
975.96
689.74
561.37
439.53
724.65
688.25
675.87
599.27
Accumulated Depreciation
313.14
232.21
169.67
115.29
74.15
36.92
308.66
268.96
228.11
190.87
Non Current Assets
1,734.44
1,455.33
1,093.64
853.59
772.27
673.34
589.07
563.97
594.06
547.20
Capital Work in Progress
567.50
330.47
92.39
238.15
249.98
237.13
122.64
90.54
132.20
112.76
Non Current Investment
159.12
134.38
129.20
9.20
9.51
5.54
5.83
5.72
5.72
0.03
Long Term Loans & Adv.
112.89
112.90
56.37
24.05
25.57
28.05
44.61
48.42
8.38
26.02
Other Non Current Assets
14.52
11.52
9.39
7.74
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,377.32
1,686.47
2,039.29
2,336.47
748.46
632.11
564.42
580.68
478.44
439.35
Current Investments
236.43
419.10
800.75
895.55
8.00
8.04
35.04
5.67
33.06
14.50
Inventories
538.34
396.54
338.66
272.86
281.71
230.57
207.68
203.49
143.05
157.96
Sundry Debtors
250.27
390.14
436.05
276.92
315.32
220.09
191.58
196.51
206.95
183.25
Cash & Bank
82.45
233.81
200.99
681.46
16.14
20.13
26.96
52.15
24.64
23.23
Other Current Assets
269.83
63.84
68.65
64.17
127.29
153.28
103.17
122.86
70.75
60.40
Short Term Loans & Adv.
207.62
183.04
194.18
145.51
98.80
122.77
82.25
105.67
61.73
53.14
Net Current Assets
871.56
1,119.74
1,536.37
1,872.95
355.84
357.02
352.66
350.36
227.32
206.05
Total Assets
3,111.76
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45
1,153.49
1,144.65
1,072.50
986.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
33.10
19.82
-327.77
-112.34
68.19
111.91
78.10
86.73
171.23
124.08
PBT
51.48
-48.21
-57.44
3,241.14
141.25
137.68
77.41
171.17
146.07
94.03
Adjustment
65.65
18.79
6.80
-3,207.66
53.31
39.65
35.57
18.74
47.15
39.37
Changes in Working Capital
-69.67
53.58
-264.94
-146.67
-98.65
-34.16
-16.49
-66.32
13.05
13.51
Cash after chg. in Working capital
47.46
24.15
-315.57
-113.20
95.91
143.16
96.49
123.58
206.27
146.91
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.36
-4.34
-12.20
0.86
-27.72
-31.25
-18.39
-36.85
-35.04
-22.83
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-73.56
-35.91
-286.01
1,648.33
-127.87
-85.33
-52.34
35.70
-118.45
-101.80
Net Fixed Assets
-328.53
-338.73
-139.02
-107.71
-135.60
154.89
-73.58
38.14
-92.98
-106.47
Net Investments
147.92
374.24
-63.59
-889.36
17.40
42.09
-32.73
20.34
-34.14
-5.98
Others
107.05
-71.42
-83.40
2,645.40
-9.67
-282.31
53.97
-22.78
8.67
10.65
Cash from Financing Activity
-121.19
-62.30
-2.42
-881.13
59.23
-33.42
-50.95
-94.92
-51.38
-14.21
Net Cash Inflow / Outflow
-161.65
-78.40
-616.19
654.86
-0.46
-6.84
-25.19
27.51
1.41
8.07
Opening Cash & Equivalents
231.52
197.05
666.07
11.21
11.67
26.96
52.15
24.64
23.23
15.16
Closing Cash & Equivalent
77.46
231.52
197.05
666.07
11.21
20.13
26.96
52.15
24.64
23.23

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
362.05
358.85
371.69
380.95
116.88
104.93
95.48
90.02
80.27
73.06
ROA
1.11%
-1.94%
-0.75%
108.06%
7.68%
8.82%
6.55%
11.56%
11.00%
7.63%
ROE
1.37%
-2.37%
-0.90%
136.04%
10.77%
11.92%
8.95%
16.62%
16.34%
11.16%
ROCE
2.12%
-1.49%
-1.77%
162.77%
13.42%
14.97%
9.29%
21.84%
20.13%
14.03%
Fixed Asset Turnover
1.08
1.06
1.43
2.21
3.08
2.32
1.71
1.67
1.71
1.55
Receivable days
94.63
136.61
109.51
78.30
63.41
55.72
58.55
64.53
65.42
76.34
Inventory Days
138.14
121.57
93.93
73.33
60.67
59.32
62.03
55.42
50.47
63.88
Payable days
70.25
76.39
73.41
94.97
104.25
52.00
52.61
62.52
65.77
65.64
Cash Conversion Cycle
162.51
181.78
130.03
56.65
19.82
63.05
67.97
57.43
50.11
74.58
Total Debt/Equity
0.04
0.07
0.08
0.06
0.09
0.04
0.03
0.03
0.04
0.11
Interest Cover
11.12
-5.25
-6.64
405.79
43.00
48.57
26.45
54.66
45.40
24.06

News Update:


  • Unichem Laboratories gets USFDA’s nod for Metformin Hydrochloride Extended-Release Tablets
    13th Aug 2021, 09:12 AM

    The product will be commercialized from Unichem's Goa Plant

    Read More
  • Unichem Laboratories reports consolidated net loss of Rs 11 crore in Q1
    2nd Aug 2021, 11:19 AM

    Total consolidated income of the company increased by 6.06% at Rs 313.70 crore for Q1FY22

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.